☆ 4.4 Letter

Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients

HAEMATOLOGICA (2021)

Get Full Text
Add to Collection

Journal

HAEMATOLOGICA
Volume 106, Issue 10, Pages 2754-2758

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2021.278888

Keywords

-

Categories

Hematology

Funding

  1. Myeloma UK
  2. Jacquelin Forbes-Nixon Fellowship
  3. Cancer Research UK [C1298/A10410]
  4. Celgene
  5. Chugai
  6. Janssen-Cilag
  7. The Binding Site
  8. Dutch Cancer Foundation
  9. German Federal Ministry of Education and Research
  10. Janssen Cilag
  11. Novartis
  12. Amgen
  13. Roche
  14. Tumorzentrum Heidelberg/Mannheim

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.